Florida's insurance regulator requested incredibly detailed prescription drug data, including patient names and birthdates.
This extensive data request from pharmacy benefit managers raises significant privacy concerns among experts.
The state claims the data is needed to ensure compliance with a 2023 drug pricing law, but critics question this justification.
Concerns exist regarding potential government overreach and misuse of sensitive patient health information.
